The Latest Breaking News from TMO

Although Thermo Fisher Scientific has lagged behind the broader S&P 500 index over the past year, analysts remain confident in its long-term growth prospects.

Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

Despite Thermo Fisher Scientific’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

December Nasdaq 100 E-Mini futures (NQZ24) are trending down -0.23% this morning as Treasury yields continued to rise on the prospect of less aggressive Federal Reserve interest rate cuts, while investors awaited a slew of corporate earnings reports, with a particular focus on results from “Magnificent Seven” member Tesla.

The health and wellness market is experiencing growth due to the rising prevalence of chronic diseases, increased consumer demand for health products, and substantial sales growth in health insurance and consumer healthcare markets. Therefore, it could be wise to watch top health and wellness stocks: UnitedHealth Group (UNH), Thermo Fisher…

Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts expect a single-digit earnings dip.

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

Despite Revvity’s underperformance compared to its industry peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.